BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho HD, Moon KD, Park KH, Lee YS, Seo KI. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo. Food Chem Toxicol 2018;121:612-21. [PMID: 30236598 DOI: 10.1016/j.fct.2018.09.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Baier A, Szyszka R. Compounds from Natural Sources as Protein Kinase Inhibitors. Biomolecules 2020;10:E1546. [PMID: 33198400 DOI: 10.3390/biom10111546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bai M, Li ZG, Ba Y. Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment. Int J Gen Med 2021;14:1041-55. [PMID: 33790633 DOI: 10.2147/IJGM.S300968] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cho HD, Gu IA, Won YS, Moon KD, Park KH, Seo KI. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway. Food Chem Toxicol 2019;126:223-32. [PMID: 30817944 DOI: 10.1016/j.fct.2019.02.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Geng N, Ding CM, Liu ZK, Song S, Hu WX. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study. Int J Clin Oncol 2021;26:670-83. [PMID: 33392882 DOI: 10.1007/s10147-020-01849-w] [Reference Citation Analysis]
5 Song ZZ, Zhao LF, Zuo J, Fan ZS, Wang L, Wang YD. Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism. Onco Targets Ther 2020;13:603-13. [PMID: 32021302 DOI: 10.2147/OTT.S222985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Cho HD, Kim JH, Park JK, Hong SM, Kim DH, Seo KI. Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. Pharm Biol 2019;57:684-93. [PMID: 31608754 DOI: 10.1080/13880209.2019.1672753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kim JY, Wang Y, Li ZP, Baiseitova A, Ban YJ, Park KH. Xanthine Oxidase Inhibition and Anti-LDL Oxidation by Prenylated Isoflavones from Flemingia philippinensis Root. Molecules 2020;25:E3074. [PMID: 32640700 DOI: 10.3390/molecules25133074] [Reference Citation Analysis]
8 Shi X, Zhang G, Ge G, Guo Z, Song Y, Su D, Shan L. In Vitro Metabolism of Auriculasin and Its Inhibitory Effects on Human Cytochrome P450 and UDP-Glucuronosyltransferase Enzymes. Chem Res Toxicol 2019;32:2125-34. [PMID: 31515991 DOI: 10.1021/acs.chemrestox.9b00307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 He D, Zhao AS, Su H, Zhang Y, Wang YN, Luo D, Gao Y, Li JA, Yang P. An injectable scaffold based on temperature-responsive hydrogel and factor-loaded nanoparticles for application in vascularization in tissue engineering. J Biomed Mater Res A 2019;107:2123-34. [PMID: 31094049 DOI: 10.1002/jbm.a.36723] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
10 Cho HD, Kim JH, Won YS, Moon KD, Seo KI. Inhibitory Effects of Pectinase-Treated Prunus Mume Fruit Concentrate on Colorectal Cancer Proliferation and Angiogenesis of Endothelial Cells. J Food Sci 2019;84:3284-95. [PMID: 31618463 DOI: 10.1111/1750-3841.14824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Liu JY, Zhu BR, Wang YD, Sun X. The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis. Int J Clin Oncol 2020;25:1195-205. [PMID: 32215805 DOI: 10.1007/s10147-020-01644-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
12 Yan Z, Gu YY, Hu XD, Zhao Q, Kang HL, Wang M, Duan W, Guan Y. Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the VEGFR2 polymorphism. Oncol Lett 2020;20:3035-45. [PMID: 32782621 DOI: 10.3892/ol.2020.11857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]